WuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam Tsang WuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam Tsang
WuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam Tsang
Pharmaceuticals
Money /  Markets & Investing

Coronavirus drugs research firm WuXi Biologics’ largest shareholder sells stake for US$893 million windfall

  • WuXi Biologics Holdings raised HK$6.1 billion by selling a 2.43 per cent stake after the market closed on Tuesday
  • WuXi’s stock has skyrocketed by about tenfold from its IPO price of HK$20.6

Topic |   Pharmaceuticals
Eric Ng
Eric Ng

Updated: 10:29pm, 2 Sep, 2020

Why you can trust SCMP
WuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam Tsang WuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam Tsang
WuXi Biologics’ stock was trading 3.1 per cent lower in Hong Kong on Wednesday afternoon. Photo: Sam Tsang
READ FULL ARTICLE